DeutschNewstral
Article
bizjournals.com on 2020-02-19 21:45
St. Louis biotech startup makes acquisition, targets commercialization
Related news
- St. Louis biotech startup makes acquisitionbizjournals.com
- St. Louis biotech startup grows again by acquisitionbizjournals.com
- St. Louis biotech startup raises $25M as it prepares for commercializationbizjournals.com
Biotech Startup NantHealth Targets IPO Market AgainInc.- Raleigh biotech startup targets $4 million raisebizjournals.com
- St. Louis biotech startup relocates to Baltimorebizjournals.com
- St. Louis biotech startup snags $20M investmentbizjournals.com
- Bruker Corp. acquires St. Louis biotech startupbizjournals.com
- St. Louis adtech startup expands with acquisitionbizjournals.com
- Biotech company launches commercialization subsidiarybizjournals.com
M&A Activity: Local biotech startup AxoSim makes an acquisitionneworleanscitybusiness.com- Behind Bristol-Myers' $600M acquisition of an Atlas biotech startupbizjournals.com
South Side biotech startup targets $6 billion heart surgery marketpost-gazette.com
New biotech startup targets genes to treat skin diseasesthenextweb.com- BioGenerator investment lures North Carolina biotech startup to St. Louisbizjournals.com
- St. Louis biotech startup taps former MilliporeSigma executive as CEObizjournals.com
- St. Louis biotech startup selected for prestigious accelerator programbizjournals.com
- St. Louis biotech startup snags $2.2M in fundingbizjournals.com
- St. Louis biotech startup Arch Oncology names new CEObizjournals.com
- St. Louis events software startup Curate makes acquisitionbizjournals.com